$1.02 5.6%
CLSD Stock Price vs. AI Score
Data gathered: December 4

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Clearside Biomedical

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.


Clearside Biomedical
Price $1.02
Target Price Sign up
Volume 276,900
Market Cap $83M
Year Range $0.93 - $1.58
Dividend Yield 0%
Analyst Rating 100% buy
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '241M2.8M-1.8M-7.7M-5.9M-0.100
Q2 '2490,0003.1M-3M-7.6M-5.2M-0.100
Q1 '24230,0002.8M-2.6M-12M-9.3M-0.150
Q4 '236.3M2.9M3.4M-4.8M-2.5M-0.080
Q3 '23860,0002.8M-1.9M-9.3M-7.1M-0.150

Insider Transactions View All

Chong Ngai Hang Victor filed to buy 100,000 shares at $1.
November 4 '24
Chong Ngai Hang Victor filed to buy 63,500 shares at $1.1.
June 24 '24
YERXA BENJAMIN R filed to buy 17,957 shares at $1.3.
May 15 '24
Gibney Anthony S filed to buy 100,000 shares at $1.3.
April 19 '24
Gibney Anthony S filed to buy 6,710 shares at $1.3.
April 19 '24

What is the Market Cap of Clearside Biomedical?

The Market Cap of Clearside Biomedical is $83M.

What is the current stock price of Clearside Biomedical?

Currently, the price of one share of Clearside Biomedical stock is $1.02.

How can I analyze the CLSD stock price chart for investment decisions?

The CLSD stock price chart above provides a comprehensive visual representation of Clearside Biomedical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Clearside Biomedical shares. Our platform offers an up-to-date CLSD stock price chart, along with technical data analysis and alternative data insights.

Does CLSD offer dividends to its shareholders?

As of our latest update, Clearside Biomedical (CLSD) does not offer dividends to its shareholders. Investors interested in Clearside Biomedical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Clearside Biomedical?

Some of the similar stocks of Clearside Biomedical are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.